Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer

被引：0
|
作者：
Kara N. Maxwell
Danielle Soucier-Ernst
Emin Tahirovic
Andrea B. Troxel
Candace Clark
Michael Feldman
Christopher Colameco
Bijal Kakrecha
Melissa Langer
David Lieberman
Jennifer J. D. Morrissette
Matt R. Paul
Tien-chi Pan
Stephanie Yee
Natalie Shih
Erica Carpenter
Lewis A. Chodosh
Angela DeMichele
机构：
[1] Perelman School of Medicine at the University of Pennsylvania,Department of Medicine, Division of Hematology
[2] Perelman School of Medicine at the University of Pennsylvania,Oncology
[3] Perelman School of Medicine at the University of Pennsylvania,Abramson Cancer Center
[4] Perelman School of Medicine at the University of Pennsylvania,Department of Biostatistics and Epidemiology
[5] Perelman School of Medicine at the University of Pennsylvania,Department of Pathology and Laboratory Medicine
[6] Diabetes and Metabolism at the Perelman School of Medicine at the University of Pennsylvania,Department of Cancer Biology
[7] NYU School of Medicine,Department of Medicine, Division of Endocrinology
[8] University of Maryland School of Medicine,Department of Population Health
来源：
Breast Cancer Research and Treatment | 2017年 / 164卷
关键词：
Metastatic breast cancer; Liquid biopsy; Cell-free DNA; Genomic testing; Massively parallel sequencing;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：627 / 638
页数：11
相关论文
共 50 条
  • [21] Clinical Utility of Analyzing Circulating Tumor DNA in Patients with Metastatic Colorectal Cancer
    Nakamura, Yoshiaki
    Yoshino, Takayuki
    ONCOLOGIST, 2018, 23 (11) : 1310 - 1318
  • [22] Brain metastases in patients with metastatic breast cancer and BRCA1/2 mutations in cell-free DNA
    Neelima Vidula
    Erica Blouch
    Katherine Hesler
    Andrzej Niemierko
    Aditya Bardia
    Breast Cancer Research and Treatment, 2025, 212 (1) : 107 - 112
  • [23] Metastatic breast cancer patient perceptions of somatic tumor genomic testing
    Elizabeth J. Adams
    Sarah Asad
    Raquel Reinbolt
    Katharine A. Collier
    Mahmoud Abdel-Rasoul
    Susan Gillespie
    James L. Chen
    Mathew A. Cherian
    Anne M. Noonan
    Sagar Sardesai
    Jeffrey VanDeusen
    Robert Wesolowski
    Nicole Williams
    Charles L. Shapiro
    Erin R. Macrae
    Robert Pilarski
    Amanda E. Toland
    Leigha Senter
    Bhuvaneswari Ramaswamy
    Clara N. Lee
    Maryam B. Lustberg
    Daniel G. Stover
    BMC Cancer, 20
  • [24] Metastatic breast cancer patient perceptions of somatic tumor genomic testing
    Adams, Elizabeth J.
    Asad, Sarah
    Reinbolt, Raquel
    Collier, Katharine A.
    Abdel-Rasoul, Mahmoud
    Gillespie, Susan
    Chen, James L.
    Cherian, Mathew A.
    Noonan, Anne M.
    Sardesai, Sagar
    VanDeusen, Jeffrey
    Wesolowski, Robert
    Williams, Nicole
    Shapiro, Charles L.
    Macrae, Erin R.
    Pilarski, Robert
    Toland, Amanda E.
    Senter, Leigha
    Ramaswamy, Bhuvaneswari
    Lee, Clara N.
    Lustberg, Maryam B.
    Stover, Daniel G.
    BMC CANCER, 2020, 20 (01)
  • [25] Recent advances in circulating tumor cells and cell-free DNA in metastatic prostate cancer: a review
    Parimi, Sunil
    Ko, Jenny J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (10) : 939 - 949
  • [26] Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer
    Fernandez-Garcia, Daniel
    Hills, Allison
    Page, Karen
    Hastings, Robert K.
    Toghill, Bradley
    Goddard, Kate S.
    Ion, Charlotte
    Ogle, Olivia
    Boydell, Anna Rita
    Gleason, Kelly
    Rutherford, Mark
    Lim, Adrian
    Guttery, David S.
    Coombes, R. Charles
    Shaw, Jacqueline A.
    BREAST CANCER RESEARCH, 2019, 21 (01)
  • [27] Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer
    Daniel Fernandez-Garcia
    Allison Hills
    Karen Page
    Robert K. Hastings
    Bradley Toghill
    Kate S. Goddard
    Charlotte Ion
    Olivia Ogle
    Anna Rita Boydell
    Kelly Gleason
    Mark Rutherford
    Adrian Lim
    David S. Guttery
    R. Charles Coombes
    Jacqueline A. Shaw
    Breast Cancer Research, 21
  • [28] Cell-free DNA as a biomarker in cancer
    Eibl, Robert H.
    Schneemann, Markus
    EXTRACELLULAR VESICLES AND CIRCULATING NUCLEIC ACIDS, 2022, 3 (03): : 195 - 215
  • [29] Cell-free DNA as a novel marker in cancer therapy
    Kato, Shumei
    Janku, Filip
    BIOMARKERS IN MEDICINE, 2015, 9 (07) : 703 - 712
  • [30] Clinical utility of plasma cell-free DNA in pancreatic neuroendocrine neoplasms
    Cowzer, Darren
    Shah, Ronak H.
    Chou, Joanne F.
    Kundra, Ritika
    Punn, Sippy
    Fiedler, Laura
    DeMore, April
    Capanu, Marinela
    Berger, Michael F.
    Reidy-Lagunes, Diane
    Raj, Nitya
    ENDOCRINE-RELATED CANCER, 2024, 31 (04)
12345